Robust and reliable amplification of long unknown sequence by RACE. Obtaining a full-length cDNA is of critical importance for structural and expression studies. The amplification of DNA sequences from a messenger RNA template between a defined internal site and unknown sequences of either the 3' or the 5' end of the mRNA are often referred to as RACE (rapid amplification of cDNA ends), “anchored” PCR, or “one-sided” PCR. Transcriptor Reverse Transcriptase is supplied with the kit to transcribe full-length cDNA up to 14 kb in length and, due to the thermostability of Transcriptor Reverse Transcriptase (up to 65°C), to work with GC-rich templates with high secondary structure. In addition, with Transcriptor Reverse Transcriptase, high sensitivity can be achieved. This results in highly efficient cDNA synthesis and the generation of long RACE products. Purification of the first-strand cDNA is performed with the High Pure PCR Product Purification Kit. Recombinant Terminal Transferase is used to add a homopolymeric A-tail to the 3' end of the cDNA. The use of poly(A) tail decreases the likelihood of inappropriate trunction by the oligo dT-anchor primer, and due to the weaker A/T binding compared to the G/C binding, longer stretches of A residues are required before the oligo dT-anchor primer will bind to an internal site and truncate the amplification product. Tailed cDNA is amplified by PCR using a gene-specific primer and the oligo dT-anchor primer. The obtained cDNA is further amplified by a second PCR using a nested specific primer and the PCR anchor primer. As a result, the RACE products can be cloned into an appropriate vector for subsequent characterization studies.
Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Protein Protects Against Flu in Mice The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.Cat Stem Cell Therapy Gives Humans Hope By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.